Peptide Schedule
DSIP9 residuesWAGGDASGEEach bubble = one amino acid. Size = residue mass. Color = chemical class.DSIP
Benefits
About DSIP
DSIP (Delta Sleep Inducing Peptide) is a naturally occurring neuropeptide that promotes deep, restorative delta-wave sleep. Unlike sleeping pills, it doesn't force sedation — it normalizes the sleep architecture so you fall asleep naturally and achieve deeper slow-wave sleep phases. It's non-addictive with no morning grogginess. Research also shows it may normalize cortisol and stress hormones, and improve LH (luteinizing hormone) release.
Who Should Consider DSIP
- Adults with disrupted sleep architecture or difficulty reaching deep sleep
- Shift workers needing to reset circadian patterns
- Individuals with elevated cortisol or chronic stress affecting sleep
- Those seeking a non-habit-forming alternative to pharmaceutical sleep aids
- Athletes looking to optimize recovery through improved sleep quality
How DSIP Works
DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is a nonapeptide with a molecular weight of 849 Da that crosses the blood-brain barrier via a non-competitive, non-saturable mechanism — unusual for a peptide of its size. In plasma it has a free half-life of only 7-8 minutes, but in vivo it complexes with carrier proteins that protect it from aminopeptidase degradation and extend its functional duration to several hours. Once in the CNS, DSIP modulates sleep architecture through multiple pathways. It interacts with NMDA receptors in the hypothalamus and limbic system, promoting the transition into slow-wave (delta) sleep without suppressing REM sleep the way benzodiazepines do. It also stimulates pineal acetyltransferase activity through alpha-1 adrenergic receptors, which increases melatonin synthesis — reinforcing the natural circadian sleep signal. Beyond sleep, DSIP acts as a stress-limiting factor at the hypothalamic-pituitary-adrenal axis. It decreases basal corticotropin (ACTH) levels and blocks stress-induced ACTH release, which in turn lowers cortisol. It also stimulates hypothalamic LH-releasing hormone secretion, producing a measurable rise in luteinizing hormone within 30 minutes of central administration. Additional research shows DSIP suppresses lipid peroxidation and activates endogenous antioxidant defense systems, suggesting a neuroprotective role that may contribute to its restorative sleep effects.
What to Expect
Most users notice faster sleep onset and more vivid dreams within the first few nights. Effects are subtle — this is not a sedative.
Deeper sleep becomes more consistent. Morning alertness improves. Some report reduced middle-of-the-night waking.
Sleep architecture normalizes. Cortisol patterns may improve. Cumulative recovery benefits become apparent — better mood, reduced brain fog.
Full benefits plateau. Most protocols call for cycling off at this point (2-4 weeks off) to maintain sensitivity.
Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 200mcg | Daily |
| Aggressive | 300mcg | Daily |
Note: Delta Sleep Inducing Peptide. Dose 30-60 min before bed. Non-addictive and non-habit-forming. Commonly cycled 2-4 weeks on, 2 weeks off. May normalize disrupted sleep patterns.
How to Inject DSIP
Reconstitute a 5mg vial with 2mL bacteriostatic water (2.5mg/mL concentration). Inject subcutaneously 30-60 minutes before bed. Beginner dose is 100mcg (0.04mL), moderate is 200mcg (0.08mL), aggressive is 300mcg (0.12mL). Use an insulin syringe for accuracy at these small volumes. Abdomen or upper arm are preferred injection sites. IV administration was used in clinical studies but is not practical for home use.
Cycling Protocol
Typical protocol is 2-4 weeks on, 2 weeks off. No dependence or withdrawal has been reported, but cycling preserves receptor sensitivity. Some users run 5 days on, 2 days off within each active week.
Pharmacokinetics
Source: Kastin et al. — plasma degradation studies; functional duration extended by carrier protein binding
Loading the interactive decay curve.
Side Effects
Very well-tolerated. Occasional vivid dreams. No dependence or withdrawal effects.
Contraindications
- Pregnancy or breastfeeding — no safety data exists for fetal or infant exposure
- Known hypersensitivity to DSIP or any component of the formulation
- Severe hypotension — DSIP may modestly lower blood pressure through stress-hormone reduction
- Children and adolescents — not studied in pediatric populations
Drug Interactions
- Benzodiazepines and other GABAergic sedatives — potential additive CNS depression; avoid concurrent use or reduce sedative dose
- Antihypertensive medications — DSIP may enhance blood pressure lowering through cortisol reduction; monitor BP
- Corticosteroids — DSIP suppresses ACTH and cortisol release, which could theoretically interfere with exogenous corticosteroid protocols
- Melatonin supplements — overlapping mechanism via pineal acetyltransferase stimulation; combined use is likely redundant rather than dangerous
Storage & Stability
Molecular Profile
Related Peptides
References
- Delta-sleep-inducing peptide (DSIP): a reviewPubMed 6145137
- Acute and delayed effects of DSIP on human sleep behaviorPubMed 6895513
- Effects of DSIP on sleep of chronic insomniac patients — double-blind studyPubMed 1299794
- DSIP stimulates the release of LH via a hypothalamic site of action in the ratPubMed 3121137
- DSIP response to human CRH in major depressive disorder — cortisol correlationPubMed 2839244
- DSIP: a still unresolved riddle — comprehensive reviewPubMed 16539679